Navigation Links
Medicare Spending Caps Cause Seniors to Stop Meds
Date:9/11/2007

In many cases, patients never take these important medications again, study finds

TUESDAY, Sept. 11 (HealthDay News) -- Some American seniors stop taking medications for chronic health problems such as high blood pressure and diabetes when they exceed spending limits in their Medicare prescription drug plans, new research shows.

The study, by the nonprofit research organization the RAND Corporation, also found that many of those seniors do not resume taking their prescription drugs when their drug benefits kick in again at the start of a new health plan year.

The RAND team analyzed prescription drug use from 2003 to 2005 among 60,000 seniors enrolled in a health plan offered by a large national employer. The seniors were enrolled in one of three drug plans: one with a spending limit of $1,000; one with a spending limit of $2,500; and one with no spending limit. In each of the plans, enrollees had to pay a portion of their drug purchases.

The study looked at the use of drugs to treat high blood pressure, cardiac problems, diabetes, ulcers, depression, and prescription pain medications that have over-the-counter substitutes.

Reporting in the Sept./Oct. issue of the journal Health Affairs, the researchers found that 6 percent to 13 percent of seniors enrolled in drug plans with spending caps reached their spending limit in each of the years of the study. Of those who reached their spending limits, about half went without drug benefits for more than 90 days.

Seniors in capped plans who spent the most on drugs were more likely to discontinue their use of medications than those in plans with no cap.

Discontinuation of drugs varied from 15 percent for anti-cholesterol medications to 28 percent for cardiac drugs, the study found.

"Prescription use falls significantly as patients reach their benefit caps," lead author Geoffrey Joyce, a senior economist at RAND, said in a prepared statement. "Most of the drugs we studied help prevent long-term complications of chronic disease, so there are likely to be adverse health consequences for seniors who hit their caps."

"Drug caps are a cost-saving measure, but our findings raise the issue of whether in the long run they may lead to other medical cost such as increased hospitalizations," senior author Dana Goldman, director of health economics at RAND, said in a prepared statement.

More information

Medicare has more about Plan D drug coverage.



-- Robert Preidt



SOURCE: RAND Corporation, news release, Sept. 11, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Medicare Drug Deadline not to be extended
2. House heads for Medicare drug vote
3. New Medicare Plan - Mixed Reaction among Pharmacists.
4. Medicare Data would help in Drug Validation
5. Medicare Queries Expected To Increase Over Time
6. Medicare to cover services provided by rural health care personnels.
7. Cancer test expenses taken up by Medicare
8. Nurse Practitioners Are Not Recognized By Medicare
9. Medicare Drug Plan Is Not Working in The US
10. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
11. Rising Medicare costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... According to an article ... account for a significant portion of hernia repairs throughout the United States. Commenting on ... Hernia Center notes that this trend has not only been expected, but it seems ...
(Date:2/12/2016)... ... 12, 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett ... of these scholarships is to encourage applicants to pursue a degree in their field ... two parishes. , “We have available jobs in St. Landry and Evangeline Parishes ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... community at its 10th anniversary Fashion Luncheon on Monday, February 8, 2016. The ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... cycle of pharmaceutical products, garnering increased attention from all stakeholders in the development ...
(Date:2/12/2016)... ... 12, 2016 , ... As a former television executive, owner Tal Rabinowitz knows ... time to decompress, Rabinowitz found herself drawn to a casual meditation class while working ... her life, implementing a 20-minute-per-day meditation practice with her team. After her tenure at ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... -- Eli Lilly and Company (NYSE: LLY ) today announced ... vitamin regimen patent would not presently be infringed by Actavis ... , Italy and Spain ... dextrose solution.  --> --> ... held that Lilly,s patent would be indirectly infringed by Actavis ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis ... completed a $47.1 million Series D preferred ... Asset Management, Hillhouse Capital Group and venBio ... Venture Investments, AJU IB Investment, and Epidarex ... used to further advance clinical trials in ...
(Date:2/11/2016)... 2016 The primary goal of this research ... on the usage of liquid biopsy. Key information the ... - Timeframe of liquid biopsy adoption amidst future users ... organization type - Sample inflow to conduct liquid biopsy ... serum, and so on. - Correlation analysis of sample ...
Breaking Medicine Technology: